Susan Hasty, Publisher
Table of Contents . . . December 13th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Cystic Fibrosis - AAV Vectors Safe for Repeated Delivery to Rabbit Airway
Antisense Technology - Oligonucleotide Has Enhanced Antiviral Activity
Antisense Technology (Prostate Cancer) - Androgen Independence is Delayed by Adjuvant Treatment
DNA Vaccines - Salivary Gland Immunization Elicits Specific Antibodies
Gene Expression - Gene Activation by Tripler-Forming Oligonucleotides Studied
Spinal Cord Injury - Delayed Treatment Proves Helpful in Rats
Tissue Engineering (Muscle) - New Technologies Dependent on Gene Therapy
Tissue Engineering (Orthopedic) - New Strategies Linked to Gene Transfer Technology
Arthritis - Gene Transfer Induces Apoptosis of Synoviocytes
Arthritis - IL-4 Gene Transfer Reduces Inflammation in Rat Model
Glomerular Disease - Gene Therapy: A New Treatment for Interstitial Fibrosis
Non-Small Cell Carcinoma (Clinical Trials) - Phase III Trials of ISIS 3521 Will Begin in 2000
Transplant Immunotherapy - Gene Transfer Prolongs Allograft Survival
Angioendothelioma (Treatment) - Second Clinical Trial Underway for Interferon-a Gene Medicine
Vector Development - Company Issues Statement Regarding Use of AAV Vectors
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.